Abstracts

Primary Percutaneous Intervention is the most advantageous and rewarding reperfusion strategy available in patients with acute ST-segment–elevation myocardial infarction (STEMI), although it fails to restore optimal myocardial reperfusion in a sizeable portion of patients mostly because of no-reflow phenomenon.

No reflow is defined as suboptimal myocardial reperfusion through a part of coronary circulation without angiographic evidence of mechanical vessel obstruction. Inflammation has a substantial role in the initiation and propagation of the atherosclerotic process. The platelet–lymphocyte ratio (PLR) has been recently proposed to be a marker of thrombotic and inflammatory state, mainly in patients with coronary or peripheral ischemic events.

Abbreviations: PPCI: Primary Percutaneous Coronary Intervention; PCI: Percutaneous Coronary Intervention; STEMI: Segment Elevation Myocardial Infarction; PLR: Platelet to Lymphocyte Ratio; TIMI: Thrombolysis in Myocardial Infarction